These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8121073

  • 41. Modification of measurement of effective renal plasma flow from blood pool clearance curve of I-123-orthoiodohippurate using single blood sampling.
    Akutsu T, Komatani A, Yamaguchi K, Takahashi K, Konta T.
    Radiat Med; 1998; 16(4):245-50. PubMed ID: 9814418
    [Abstract] [Full Text] [Related]

  • 42. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U, Cordes M, Wilfling M, Hunger J, Hosten N, Gahl G.
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Normal ranges of renal physiological parameters for technetium-99m mercaptoacetyltriglycine and the influence of age and sex using a camera-based method.
    Lin WY, Changlai SP, Kao CH.
    Urol Int; 1998 Mar; 60(1):11-6. PubMed ID: 9519415
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
    Taylor A, Eshima D, Christian PE, Milton W.
    Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Off-site determinations of effective renal plasma flow using technetium-99m-MAG3 and single blood sampling.
    Vines D, Denhartog P, Kwan D, Ichise M.
    J Nucl Med Technol; 1998 Mar; 26(1):23-5. PubMed ID: 9549688
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A, Eshima D.
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Pharmacokinetics of technetium-99m-MAG3 in humans.
    Bubeck B, Brandau W, Weber E, Kälble T, Parekh N, Georgi P.
    J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
    [Abstract] [Full Text] [Related]

  • 60. [Quantification of renal function with 99mTc-MAG3--quantification of tubular extraction rate using Bubeck's method].
    Yamazaki T, Maruoka S, Sakamoto K.
    Kaku Igaku; 1995 Nov; 32(11):1199-206. PubMed ID: 8558788
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.